Projects per year
Fingerprint
Dive into the research topics where Asher A Chanan Khan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
Therapeutic implication of CD38 in CLL
Chanan Khan, A. A. (PI) & Chini, E. N. (CoPI)
9/4/19 → 8/31/24
Project: Research project
-
VACCINE FOR PATIENTS WITH NON HODGKINS LYMPHOMA
Chanan Khan, A. A. (PI) & Bernstein, S. H. (CoPI)
9/18/00 → 9/1/03
Project: Research project
-
A phase II study of daratumumab and ibrutinib for relapsed/refractory chronic lymphocytic leukemia
Parrondo, R. D., Ailawadhi, S., Knopf, B. R., Zimmerman, A., Kasik, C. J., Chapin, D., Heslop, K., Roy, V., Paulus, A. & Chanan-Khan, A. A., Dec 2026, In: Blood cancer journal. 16, 1, 69.Research output: Contribution to journal › Letter › peer-review
Open Access -
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Mayo Clinic Systematic Management and Risk-Adapted Therapy for Lymphoid Malignancies (lySMART) Consensus Guidelines 2026
Parikh, S. A., Hampel, P. J., Roeker, L. E., Wang, Y., Tsang, M., Parrondo, R., Bailen, R., Koehler, A., Behnken, A. L., Wagner, C. C., Hilal, T., Ailawadhi, S., Munoz, J. L., Rosenthal, A. C., Chanan-Khan, A., Zepeda-Mendoza, C. J., King, R. L., Hanson, C. A., Braggio, E. & Slager, S. L. & 5 others, , 2026, (Accepted/In press) In: Mayo Clinic proceedings.Research output: Contribution to journal › Article › peer-review
-
Multi-omics analysis reveals a unique epigenetic signature in MYD88 wild-type Waldenström macroglobulinemia
Chohan, K., Paludo, J., Dasari, S., Novak, J. P., Abeykoon, J. P., Zanwar, S., Yang, Z. Z., Jalali, S., Bhardwaj, V., Krull, J. E., Braggio, E., Manske, M. K., Reeder, C. B., Ailawadhi, S., Chanan-Khan, A., Kapoor, P., Kyle, R. A., Gertz, M., Novak, A. J. & Mondello, P. & 1 others, , May 1 2026, In: Haematologica. 111, 5, p. 1852-1857 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Number needed to treat to avoid progression and death and cost analysis: zanubrutinib versus acalabrutinib in relapsed/refractory chronic lymphocytic leukemia
Shadman, M., Chanan-Khan, A., Campbell, D., Xue, M., Massoudi, M., Williams, R., Yang, K. & Tam, C. S., 2026, In: Future Oncology. 22, 3, p. 339-348 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Real-World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated With Front-Line Daratumumab Lenalidomide and Dexamethasone
Parrondo, R. D., de Menezes, R. C. B., Sledge, H., Nayyar, M., Yadav, K., Bergsagel, L., Fonseca, R., Kapoor, P., Buadi, F., Gertz, M. A., Dispenzieri, A., Roy, V., Abdallah, N., Chhabra, S., Rajkumar, S. V., Gonsalves, W. I., Cook, J., Kumar, S., Chanan-Khan, A. A. & Ailawadhi, S., Apr 2026, In: American journal of hematology. 101, 4, p. 884-888 5 p.Research output: Contribution to journal › Letter › peer-review